| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K52037352 | CTRPv2 | pan-cancer | AAC | 0.0051 | 0.9 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.9 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.0067 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | -0.0038 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.0039 | 0.9 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | -0.8 | 0.9 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.9 |